Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // December 7th, 2009 // 8:05 am
Welcome to the working week. We hope your weekend was pleasant and invigorating. Now, though, the routine returns. And with it come the usual onslaught of meetings, deadlines and projects. So grab a cup of stimulation and get ready. To help you along, here are a few items of interest. Hope your day is tolerable…
Celgene To Buy Gloucester In $640M Deal (Associated Press/nj.com)
Glaxo Launches $15M Ad Campaign For Nicorette (Forbes)
Roche Family Holdings Decline (MPT Online)
Rexahn Pharma Looks For A Big-Pharma Deal (Washington Business Journal)
FDA Wants More Details On Opioid Drug Misuse (MSNBC.com)
Data Exclusivity Causes Debate In India (The Business Standard)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Celgene, Data Exclusivity, GlaxoSmithKline, Gloucester Pharmaceuticals, India, Nicorette, Opioids, Rexahn Pharmaceuticals